{
    "2021-11-04": [
        [
            {
                "time": "2021-11-01",
                "original_text": "【兴证医药】医药持仓比例历史低位，自下而上布局2022年-2021年11月投资月报",
                "features": {
                    "keywords": [
                        "医药",
                        "持仓比例",
                        "历史低位",
                        "自下而上",
                        "布局"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-02",
                "original_text": "高瓴，正在抛弃医药股？",
                "features": {
                    "keywords": [
                        "高瓴",
                        "医药股",
                        "抛弃"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-03",
                "original_text": "全球首个皮下注射、国产首个PD-L1即将获批！国内已上市的PD-（L）1大盘点",
                "features": {
                    "keywords": [
                        "PD-L1",
                        "获批",
                        "国产",
                        "全球首个"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-04",
                "original_text": "恒瑞医药现1笔大宗交易 共成交1,304.49万元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-05",
                "original_text": "恒瑞医药今日大宗交易成交29.50万股，成交价44.22元折价13.65%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "折价"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-06",
                "original_text": "福布斯富豪榜：孙飘扬家族跌落前十，钟睒睒新首富",
                "features": {
                    "keywords": [
                        "福布斯富豪榜",
                        "孙飘扬",
                        "钟睒睒",
                        "新首富"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-07",
                "original_text": "北向资金稳步加仓连续6日净买入，新能源、大消费集体获抢筹",
                "features": {
                    "keywords": [
                        "北向资金",
                        "加仓",
                        "净买入",
                        "新能源",
                        "大消费"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源",
                        "大消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-08",
                "original_text": "2021年11月投资月报：医药持仓比例历史低位 自下而上布局2022年",
                "features": {
                    "keywords": [
                        "医药",
                        "持仓比例",
                        "历史低位",
                        "自下而上",
                        "布局"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-09",
                "original_text": "高瓴资本3季度只减仓不加仓：安全边际、成长性重定位",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "减仓",
                        "安全边际",
                        "成长性"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-10",
                "original_text": "A股融资融券日报：两融余额减少44.29亿元（11月3日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "减少"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "整体市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-11",
                "original_text": "高瓴资本三季度只减仓不加仓，安全边际与成长性需重新定位",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "减仓",
                        "安全边际",
                        "成长性",
                        "重新定位"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}